Christopher P. Venner, Sonja Zweegman, Shaji Kumar, Thierry Facon, Aurore Perrot, Philippe Moreau, Noopur S. Raje, Cyrille Hulin, Supratik Basu, Vania Hungria, Yael C. Cohen, Hartmut Goldschmidt, George C. Wang, Kasey Bolyard, Lorena Lopez-Masi, Matteo Loi, Fredrik Borgsten, Melissa Rowe, Nizar Jacques J. Bahlis, Saad Z. Usmani. "Age and frailty analyses of transplant-ineligible (TIE) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the phase 3 MAIA and CEPHEUS trials of daratumumab + lenalidomide-dexamethasone (Rd) and bortezomib-Rd (VRd).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7569